NURS FPX 4905 Assessment 2

NURS FPX 4905 Assessment 2 Define and Analyze Your Healthcare Process Problem or Issue of Concern

Name

Capella university

NURS-FPX4905 Capstone Project for Nursing

Prof. Name

Date

Define and Analyze Your Healthcare Process Problem or Issue of Concern

The practicum experience at The Longevity Center provides opportunities to actively participate in integrative and regenerative medicine practices that prioritize natural and patient-centered care. The purpose of this practicum is to enhance clinical knowledge and decision-making skills while engaging with innovative therapies that address chronic illnesses at their root cause. This paper examines the practicum setting, outlines the clinical and operational decision-making process, and identifies a critical process issue related to diagnosis and treatment outcomes in regenerative medicine.

Practicum Setting Overview

The Longevity Center is a regenerative and integrative medical clinic that merges conventional medical approaches with modern alternative therapies. The primary mission of the clinic is to promote wellness through patient-centered care and advanced regenerative methods. The patient population includes both healthy individuals seeking preventive or anti-aging therapies, as well as patients with chronic health conditions requiring regenerative interventions. This diversity creates a comprehensive learning environment that allows students and practitioners to observe different stages of illness prevention and recovery (The Longevity Center, 2024a).

The clinic is staffed by three full-time healthcare providers who operate in a highly collaborative manner. Despite its small team, the clinic functions through shared decision-making, where treatment plans are personalized, and responses to therapy are continually assessed. The practicum experience includes involvement in treatment planning, reviewing lab results, and participating in team discussions about therapy options. Additionally, The Longevity Center invests in education through clinical experiences, literature, and digital resources, which fosters a dynamic environment for professional growth, critical analysis, and improved patient care (The Longevity Center, 2024a).

Clinical and Operational Decision-Making at The Longevity Center

Clinical and operational decision-making are central to the daily functioning of The Longevity Center.

Clinical Decisions

The clinical team focuses on determining the most appropriate regenerative therapy for each patient. Decisions include:

• Selecting between Platelet-Rich Plasma (PRP) or stem cell injections.
• Determining treatment frequency and dosage.
• Assessing eligibility for regenerative care using advanced diagnostic tools such as the Longevity blood panel (The Longevity Center, 2024b).

Operational Decisions

Operational aspects include patient scheduling, documentation, resource allocation, and inventory management for biological materials. Practicum students are actively involved in observing these processes and contribute to discussions about improving efficiency.

Table 1. Examples of Clinical vs. Operational Decision-Making

These decisions directly impact patient outcomes, including reductions in inflammation, quicker tissue recovery, improved mobility, and higher satisfaction levels. Patient progress is monitored through range-of-motion testing, follow-up visits, and satisfaction surveys, reinforcing the clinic’s commitment to individualized, evidence-based care (Majewska et al., 2025).

Identifying a Process Issue Related to Diagnosis and Outcomes

One of the most significant challenges at The Longevity Center lies in delayed and inconsistent diagnostic processes. Many patients arrive after unsuccessful experiences at conventional facilities, often without a definitive diagnosis. These individuals typically suffer from chronic pain, autoimmune disorders, or fatigue syndromes. Conventional healthcare systems generally focus on managing symptoms rather than identifying root causes, which leaves many patients with unresolved conditions (Dutra et al., 2025).

Regenerative therapies, while promising, are expensive and technologically complex, making accessibility an additional barrier. For instance, patients with chronic joint pain are often directed toward medication or surgery before exploring regenerative alternatives like PRP therapy. This creates a gap in care delivery where patients undergo unnecessary procedures before accessing minimally invasive regenerative treatments.

At The Longevity Center, the intake process often requires repeating diagnostic evaluations due to incomplete or insufficient prior assessments. This not only delays treatment initiation but also negatively affects health outcomes, causing prolonged discomfort, psychological strain, and distrust in the healthcare system.

Table 2. Impact of Diagnostic Delays

According to Slawomirski et al. (2025), diagnostic errors cost OECD nations up to 17.5% of healthcare expenditure. Nearly 60–70% of new patients at The Longevity Center report dissatisfaction with previous diagnostic experiences, further emphasizing the need for streamlined and standardized diagnostic procedures.

Impact Analysis of Diagnostic Delays on Quality, Safety, and Cost

Delays in diagnosis at The Longevity Center have direct implications for quality, safety, and financial sustainability.

Quality of Care

When diagnostic delays occur, the initiation of appropriate therapy is postponed, which lowers the effectiveness of regenerative treatments. Incorrectly matched therapies can further reduce treatment outcomes and patient satisfaction (Popescu et al., 2021).

Patient Safety

Untimely or incorrect diagnoses may lead to worsening chronic conditions, such as persistent inflammation or tissue damage. In severe cases, patients may require surgical interventions that could have been avoided through timely regenerative treatments (Kvarnström et al., 2021).

Financial Cost

Extended diagnostic procedures increase costs for both patients and the clinic. For example, PRP injections can cost anywhere from \$707 to \$1,797, while bone marrow aspiration (BMA/BMC) treatments average \$3,688–\$4,379 (Charnoff et al., 2022). Since many of these treatments are not covered by insurance, financial burdens often discourage continued care, which compromises long-term outcomes.

Conclusion

The practicum at The Longevity Center highlights the potential of regenerative medicine to transform patient outcomes. However, a critical process issue—diagnostic delays—limits the effectiveness of these therapies. By standardizing diagnostic procedures, the center can significantly improve quality, safety, and cost-effectiveness of care. Addressing this issue will not only enhance patient satisfaction and trust but also strengthen the clinic’s ability to fulfill its mission of providing sustainable, natural, and effective treatments for chronic conditions.

References

Charnoff, J., Rothman, R., Andres Bergos, J., Rodeo, S., Casey, E., & Cheng, J. (2022). Variability in patient-incurred costs and protocols of regenerative medicine procedures for musculoskeletal conditions in the United States. HSS Journal®: The Musculoskeletal Journal of Hospital for Special Surgery, 19(1), 77–84. https://doi.org/10.1177/15563316221105880

Dutra, S., Reigado, G. R., Santos, M., Sardinha, D., Hernandes, S., Marchi, B. L., Zhivov, E., Chambergo, F. S., & Nunes, V. A. (2025). Advances in regenerative medicine-based approaches for skin regeneration and rejuvenation. Frontiers in Bioengineering and Biotechnology, 13. https://doi.org/10.3389/fbioe.2025.1527854

Kvarnström, K., Westerholm, A., Airaksinen, M., & Liira, H. (2021). Factors contributing to medication adherence in patients with a chronic condition: A scoping review of qualitative research. Pharmaceutics, 13(7), 1100. https://doi.org/10.3390/pharmaceutics13071100

NURS FPX 4905 Assessment 2 Define and Analyze Your Healthcare Process Problem or Issue of Concern

Majewska, L., Kijowski, J., & Dorosz, K. (2025). Effect of patient age on Platelet-Rich Plasma (PRP) and fibrin treatments for skin density and thickness: A single-center ultrasound study. Life, 15(2), 308–308. https://doi.org/10.3390/life15020308

Popescu, M. N., Iliescu, M. G., Beiu, C., Popa, L. G., Mihai, M. M., Berteanu, & Ionescu, A. M. (2021). Autologous platelet-rich plasma efficacy in the field of regenerative medicine: Product and quality control. BioMed Research International, 2021, 1–6. https://doi.org/10.1155/2021/4672959

Slawomirski, L., Kelly, D., de Bienassis, K., Kallas, K.-A., & Klazinga, N. (2025). The economics of diagnostic safety. Organisation for Economic Co-operation and Development Health Working Papers. https://doi.org/10.1787/fc61057a-en

NURS FPX 4905 Assessment 2 Define and Analyze Your Healthcare Process Problem or Issue of Concern

The Longevity Center. (2024a). Integrative and regenerative treatments. The Longevity Center FL – Nurturing Health at Its Source. https://www.thelcfl.com/

The Longevity Center. (2024b). PRP injections. The Longevity Center FL – Nurturing Health at Its Source. https://www.thelcfl.com/our-services/regenerative-therapies/prp-injections/